Viewing Study NCT04447768


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2025-12-25 @ 3:06 PM
Study NCT ID: NCT04447768
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-14
First Post: 2020-06-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module